Response of human periosteal cells to degradation products of zinc and its alloy.


Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 11 06 2019
revised: 05 09 2019
accepted: 15 09 2019
entrez: 12 1 2020
pubmed: 12 1 2020
medline: 7 10 2020
Statut: ppublish

Résumé

Zinc (Zn) and its alloys are proposed as promising resorbable materials for osteosynthesis implants. Detailed studies should be undertaken to clarify their properties in terms of degradability, biocompatibility and osteoinductivity. Degradation products of Zn alloys might affect directly adjacent cellular and tissue responses. Periosteal stem cells are responsible for participating in intramembranous ossification during fracture healing. The present study aims at examining possible effects emanating from Zn or Zn-4Ag (wt%) alloy degradation products on cell viability and osteogenic differentiation of a human immortalized cranial periosteal cell line (TAg cells). Therefore, a modified extraction method was used to investigate the degradation behavior of Zn and Zn-4Ag alloys under cell culture conditions. Compared with pure Zn, Zn-4Ag alloy showed almost fourfold higher degradation rates under cell culture conditions, while the associated degradation products had no adverse effects on cell viability. Osteogenic induction of TAg cells revealed that high concentration extracts significantly reduced calcium deposition of TAg cells, while low concentration extracts enhanced calcium deposition, indicating a dose-dependent effect of Zn ions. Our results give evidence that the observed cytotoxicity effects were determined by the released degradation products of Zn and Zn-4Ag alloys, rather than by degradation rates calculated by weight loss. Extracellular Zn ion concentration was found to modulate osteogenic differentiation of TAg cells. These findings provide significant implications and guidance for the development of Zn-based alloys with an optimized degradation behavior for Zn-based osteosynthesis implants.

Identifiants

pubmed: 31924034
pii: S0928-4931(19)32155-1
doi: 10.1016/j.msec.2019.110208
pii:
doi:

Substances chimiques

Alloys 0
Biocompatible Materials 0
Zinc J41CSQ7QDS

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110208

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Ping Li (P)

Section Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany.

Jingtao Dai (J)

Department of Oral and Maxillofacial Surgery, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany.

Ernst Schweizer (E)

Section Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany.

Frank Rupp (F)

Section Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany.

Alexander Heiss (A)

Research Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, Schwäbisch Gmünd, 73525, Germany.

Andreas Richter (A)

Research Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, Schwäbisch Gmünd, 73525, Germany.

Ulrich E Klotz (UE)

Research Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, Schwäbisch Gmünd, 73525, Germany.

Jürgen Geis-Gerstorfer (J)

Section Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany.

Lutz Scheideler (L)

Section Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany.

Dorothea Alexander (D)

Department of Oral and Maxillofacial Surgery, University Hospital Tübingen, Osianderstrasse 2-8, Tübingen, 72076, Germany. Electronic address: Dorothea.Alexander@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH